Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study. by Byford M et al.
BioMed CentralBMC Geriatrics
ssOpen AcceResearch article
Lewy bodies and neuronal loss in subcortical areas and disability in 
non-demented older people: a population based neuropathological 
cohort study
M Byford1, C Brayne1, I McKeith2, M Chatfield1, PG Ince3, FE Matthews*4 and 
MRC CFAS Neuropathology group
Address: 1Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, 2Institute for Ageing and Health, Campus for 
Ageing and Vitality, Newcastle University, Newcastle upon Tyne UK, 3Academic Unit of Pathology, University of Sheffield Medical School, 
Sheffield UK and 4MRC Biostatistics Unit, Cambridge, UK
Email: M Byford - michelle.byford@cantab.net; C Brayne - carol.brayne@phpc.cam.ac.uk; I McKeith - i.g.mckeith@newcastle.ac.uk; 
M Chatfield - Mark.Chatfield@mrc-hnr.cam.ac.uk; PG Ince - P.G.Ince@sheffield.ac.uk; FE Matthews* - Fiona.matthews@mrc-bsu.cam.ac.uk; 
MRC CFAS Neuropathology group - Fiona.matthews@mrc-bsu.cam.ac.uk
* Corresponding author    
Abstract
Background: Functional disability, the loss of ability to carry out daily tasks unaided, is a major
adverse outcome more common with increasing age. The potential contribution of
neuropathological changes in subcortical areas of the brain associated with normal ageing may be
a contributing factor to this loss of function. This study investigates the clinicopathological
relationship between functional ability during life and pathological correlates identified at post
mortem in an UK population of older people (66–102 years).
The aim is to examine the clinicopathological correlates of functional disability in subcortical
neuronal populations of non-demented elderly individuals.
Methods: 156 non-demented participants in the brain donation programme of the Medical
Research Council Cognitive Function and Ageing Study (MRC-CFAS) were included in this study.
Neuropathological examination was based on the CERAD protocol; pathologies of interest were
amyloid plaques, neurofibrillary tangles, Lewy bodies, vascular disease and neuronal loss. Self-
reported functional ability was scored according to a combined activities of daily living and
instrumental activities of daily living scale.
Results: Functional disability was equally common in men and women over 65 years, and in both
sexes disability was more common at older ages. Neuronal loss in several subcortical regions
elevated the risk of functional disability by three-fold (95% CI 1.3–6.6). There was evidence for a
relationship between Lewy bodies in the SN and functional disability.
Conclusion: Neuronal loss in subcortical regions is associated with functional disability in the
older population. The causal relationships are not defined and require further investigation.
Published: 15 June 2009
BMC Geriatrics 2009, 9:22 doi:10.1186/1471-2318-9-22
Received: 16 December 2008
Accepted: 15 June 2009
This article is available from: http://www.biomedcentral.com/1471-2318/9/22
© 2009 Byford et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9
(page number not for citation purposes)
BMC Geriatrics 2009, 9:22 http://www.biomedcentral.com/1471-2318/9/22Background
Functional disability may be defined as 'the loss of ability
to carry out daily tasks unaided'[1]. It has been estimated
that 11% of men and 19% of women over the age of 65
years living in the UK are functionally disabled[2]. The
effects of disease and ageing on an individual's functional
ability, and in particular their performance of activities of
daily living, is one of the most common problems that has
an impact on the health and quality of life in older people.
A priori assumptions about the cause of functional disa-
bility in the absence of an established diagnosed disease
could suggest the contribution of a subclinical burden of
morbidities associated with physical dysfunction (e.g.
arthritis, cardiorespiratory disease, cerebrovascular dis-
ease). However, neurodegeneration associated with age-
ing, most especially Parkinson's disease (PD), is a cause of
impaired physical function. The brain regions involved in
PD are also vulnerable to other degenerative processes
and can show neuronal loss in the absence of neuronal
lesions. We have therefore analysed data from a large pro-
spective, population-based cohort to investigate potential
relationships between functional disability and cerebral
degenerative disease in key subcortical regions (medulla,
pons, midbrain and basal forebrain).
The worldwide increase in longevity, and the concomitant
rise in functional disability, demands an understanding of
how brain function in ageing, and the neuropathological
substrates that underlie age-related decline, impact on
physical function. A number of neuropathological altera-
tions have been observed in the brains of older people
compared to those dying at younger ages. The occurrence
of lesions characteristic of Alzheimer' s disease, neurofi-
brillary tangles (NFT) and amyloid plaques, is an under-
appreciated feature of the brain in cognitively intact
elderly individuals[3]. Several studies have shown that a
substantial burden of Alzheimer-type pathology is found
in aged individuals with normal cognitive function [4-9].
Pathological changes associated with Parkinson's disease,
most notably the formation of Lewy bodies in the mid-
brain substantia nigra (SN), have also been reported in
cognitively normal aged individuals. In Parkinson's dis-
ease, these lesions are associated with impaired gait initi-
ation, limb rigidity and postural instability[10]. Like
Alzheimer's pathology, the prevalence of Lewy bodies has
been shown to increase with age[11]. In addition to NFT
and plaques, neuronal loss is a characteristic feature of
Alzheimer's disease and other neurodegenerative disor-
ders. Neuronal loss may be associated with normal age-
ing, though research using different procedures for
counting neurons suggests this may have been overesti-
mated[12]. Vascular disease is a known cause of demen-
tia, but also causes physical disability, e.g. through stroke.
Recently there is also increasing interest in the role of
small vessel disease as a substrate for functional decline.
Clinicopathological studies are usually based on compar-
isons of clinically defined case series, such as Alzheimer's
disease [13] or stroke[14], and often include a relatively
healthy, control brain comparison group using criteria
that include restricted neuropathological burden. Few
have explored the relationship between neuropathology
and gait, movement disorder or functional disability in an
unbiased sample of the ageing population among whom
a sub-clinical threshold of such symptoms is com-
mon[15]. Associations between functional disability and
pathologies typical of Alzheimer's disease (plaques and
NFT), Lewy bodies[16] and neuronal loss in subcortical
areas have been reported in small, mainly retrospective
studies based on highly selected individuals[17,18]. It is
important to see whether such findings extend to popula-
tion-based cohorts[19], so that their relevance to the
marked increase of functional disability in older age can
be estimated. There has been some indication from imag-
ing studies that vascular changes in subcortical regions are
associated with a decline in physical ability [20,21].
In this paper we compare functional disability and sub-
cortical neuropathology in brain donations to the Medical
Research Council Cognitive Functioning and Ageing
Study (MRC-CFAS), a prospective, longitudinal, popula-
tion-based study of dementia and physical frailty that
includes a brain donation programme. We test whether
loss of functional disability is associated with Alzheimer-
type pathology, Lewy bodies, vascular disease, and neuro-
nal loss across subcortical areas.
Methods
MRC-CFAS is a population based longitudinal study of
the population aged 65 and older, including institutional
settings with a brain donation programme. This study has
been described fully elsewhere[4,22].
In summary, at each of five centres in England and Wales
(Cambridgeshire, Gwynedd, Newcastle upon Tyne, Not-
tingham and Oxford), about 2,500 people agreed to a
structured initial interview, which collected sociodemo-
graphic information, cognitive measures (including
MMSE), medication and questions on activities of daily
living (ADL) and instrumental activities of daily living
(IADL).
A stratified subsample comprising 20% of those screened
was selected for assessment, comprising the Geriatric
Mental State (GMS version B3). This was repeated 2 years
later with a re-screen plus a new 20% subsample of those
not previously assessed together with a second assessment
interview for those who had previously been assessed.
Both assessment groups were followed up again six years
after the first interview. The GMS provides an algorithmic
dementia diagnosis.Page 2 of 9
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trained liaison officer to discuss brain donation and were
asked to consider making a 'Declaration of Intent' to make
a post-mortem brain donation. Donations relied on noti-
fication of the death of a donor to the study team, after
which the next of kin were approached to give consent for
brain donation and retention. The methods for post-mor-
tem brain donation followed a standardised protocol[4].
The cerebral hemispheres were separated and sectioned in
the coronal plane. One hemisphere was dissected, macro-
scopically examined and snap- frozen. The other half of
the brain was formalin fixed for conventional paraffin
embedding and histology [5].
This analysis is based on the first 355 brains donated from
the five centres. We report clinicopathological associa-
tions of functional disability in the non-demented sub-
sample of 155 donors for whom all data were available.
Measures
Neuropathology assessment
Neuropathology was assessed following the Consortium
to Establish a Registry of Alzheimer's Disease (CERAD)
neuropathology protocol[23] based on semiquantitative
assessment of the severity of specific lesions, including
NFT, plaques, Lewy bodies and neuronal loss. NFT were
assessed using a silver stain or immunocytochemistry to
hyperphosphorylated tau. Amyloid plaques were assessed
using silver staining or immunocytochemistry for β amy-
loid. LB were assessed by H&E staining or ubiquitin
immunocytochemistry. The severity of the pathologies
was scored as either none, mild, moderate or severe in five
subcortical brain regions: SN, nucleus basalis of Meynert
(NbM), raphé nuclei, locus ceruleus and dorsal efferent
nucleus of vagus nerve (DEX). Apart from the SN none of
these regions a regarded as predominantly associated with
motor function. For each individual a global measure of
severity was derived from the worst score across the five
regions. Vascular disease was assessed in conventionally
stained tissue sections. Lesions considered to be of poten-
tial significance included lacunes, severe arteriolar sclero-
sis, haemorrhage and marked expansion of perivascular
spaces. We combined information on the presence of such
lesions in each of the five subcortical regions. The neu-
ropathology variables were recoded to a dichotomous var-
iable (present and absent) for this analysis.
Neuropathological examination was carried out blind to
clinical or interview data. To ensure consistency between
centres, inter-rater reliability was confirmed at the start of
the study by circulation of microscopic slides. In this exer-
cise, fewer than 5% of the scores assigned were more than
one severity grade different among participants[24].
Missing information on the CERAD form was divided
according to its nature. "Don't know" and "Not Available/
Applicable" were assigned separate codes, but were
recoded to zero (absent) for the analyses presented.
Functional disability
Information on self-reported functional disability was
collected at all screening and assessment interviews. Ques-
tionnaires included questions on basic ADL, such as bath-
ing, dressing and using the toilet, and IADL which include
the more complex activities that are required for the main-
tenance of independence and optimum levels of function-
ing (e.g. shopping, cooking)[25]. From these data, a
hierarchical functional disability status was derived[26].
ADL-IADL scores were grouped into mild (IADL only)
and severe (IADL and/or ADL); both these levels indicate
that individuals would require help at least several times
per week (table 1).
Individuals who were missing information on functional
status at the last interview and whose last available inter-
view reported them to be disabled were classed as disa-
bled on the assumption that functional disability is
unlikely to improve.
Retrospective informant interviews (RINI)
In the period following brain donation, relatives were
approached to ask whether they would be willing to give
information about the deceased in the period prior to last
Table 1: Questions used in the screen and combined screen and assessment interview to collect information on ADL and IADL.
Question from screen/combined screen and assessment interview Answers
ADL-IADL disability requiring help at least several times/week
• Are you able to wash all over or bath?
• Are you able to prepare and cook a hot meal? (IADL)
• Are you able to put on your shoes and socks or stockings?
• No, needs help
• Yes with some difficulty
• Yes with no difficulty
• Mobility of subject • Usually ambulant non-housebound
• Usually ambulant housebound
• Chairfast permanently
• Bedfast permanently
IADL disability
• Are you able to do the heavy housework? (IADL)
• Are you able to shop and carry heavy bags? (IADL)
• No, needs help
• Yes with some difficulty
• Yes with no difficultyPage 3 of 9
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interviews (RINI) was to gather details of any incident
conditions or deterioration relevant to the final diagnosis
formulated after brain examination. Informant-reported
ADL and IADL were also collected. This information was
used to calculate a disability status of all individuals at
death.
There was insufficient information to assign functional
status to seven non-demented individuals included in the
sample; for these missing values no assumptions were
made about the likely status and they were excluded from
the analysis.
Dementia status
Dementia status (demented, non-demented or unknown)
for each individual was assigned by a hierarchical system
depending on the information available from each donor.
Death certificates were checked to identify new dementia
cases among those who were not demented in the last
interview. In cases where this last interview was more than
six months before death, the information from the RINI
was used to clarify the dementia status of the individual at
the time of death. When insufficient information was
available from any of these sources, individuals were
assigned a dementia status of "unknown"; this was the
case in 8% of the autopsy sample (28/355). The majority
of these individuals underwent just one interview only or
their last interview was too long before death for dementia
status to be assessed. These individuals were excluded
from the analysis.
Statistical methods
MRC-CFAS has released data at defined points. For this study
version 8.1 of the main dataset was used for the analysis of
baseline characteristics of the initial screening cohort. The
neuropathology dataset used was version 3.2. To allow a lag
between death and notification, the analyses presented in
this report are restricted to deaths before 30th June 2004. All
statistical analysis was conducted using Stata Software ver-
sion 9.0 (Stata Corporation, College Station, Texas, USA).
Comparisons between groups were performed using Pear-
son chi-square (χ2) analysis or Mann Whitney U tests as
appropriate. All p-values are two sided. To model the effect
of individual pathological variables on functional disability,
odds ratios and their 95% confidence intervals were calcu-
lated using unconditional multinomial logistic regression.
The analyses are based on non-demented individuals who
participated in at least one interview of MRC-CFAS, and sub-
sequently donated brain tissue. An overview of the flow of
these individuals from recruitment to death and subsequent
autopsy and analysis is presented in figure 1.
Ethical approval
MRC CFAS has had ethical approval from Eastern Anglia
Multicentre research ethics committee and all local ethical
committees for the duration of the study (1990 to date).
All individuals gave written informed consent.
Results
Demographic characteristics (age, sex, education, social
class) and functional disability status were compared
between those who were alive at the censoring date (n =
5,166), all individuals who died (n = 7,883) and individ-
uals who donated their brains (n = 355). Individuals who
were alive were more likely to be female, from a higher
social class, more highly educated and younger at the
baseline interview (all p < 0.001). Individuals who
donated brain tissue were slightly older at death, median
86 years versus 84 years for all deaths (p < 0.001), though
there were no large differences in education, sex or social
class, there was slight increase in individuals of non-man-
ual social class within the donation sample.
A total of 355 individuals from Cambridge, Gwynedd,
Newcastle, Nottingham and Oxford had donated brain
tissue by 30th June 2004. Of these, 172 (50%) were classi-
fied as demented before death, 155 (44%) as non-
demented and for 28 (8%) the dementia status was
unknown. Age at death in the 155 non-demented individ-
uals ranged from 68 to 102 years, and the median age at
death was 82 years for men and 86 for women. There were
similar numbers of men and women (78 men and 77
women). One man and five women were aged 95 and
over at death. The number of women steadily increased
with each age group such that over half of the women in
the sample were aged over 84 years. In contrast the men
were more evenly distributed across the entire age range.
The median time from last assessment until death in non-
demented individuals was 1.2 years (range 1 month – 7.3
years; 83% within 2 years of death). There were 84 RINI
(22 in the 31 individuals with an interview more than 2
years from death). Hence, there are just nine individuals
(6%) for whom the most recent information is more than
two years old at time of death.
Subcortical pathology
In the subcortical regions examined the most common
pathological findings were NFT (61%; 94/154) and neu-
ronal loss (46%; 71/154); plaques were present in 10%
(14/137) of individuals. Moderate of severe pathology
was seen for 22% of individuals who had neuronal loss,
28% who had plaques, 39% of the tangles and 55% of
individuals with Lewy bodies. All individuals show these
plaques in the nucleus basalis and one additionally
showed plaques in the raphé. Lewy bodies in the SN were
found in only seven individuals, with a further two indi-
viduals having Lewy bodies in the other areas examined.
However it is likely that LB pathology was underestimated
in the absence of α-synuclein immunocytochemistry.
There was no difference between men and women inPage 4 of 9
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types increased with age with increases in plaques and
NFT significant after adjusting for gender (p = 0.04 in
each).
The overall prevalence of functional disability was 27%
(42/153) for mild disability and 44% (68/153) for more
severe disability, for two individuals disability status
could not be ascertained. Disability was slightly more
common in women than men, though the difference was
not statistically significant. Stratification by age group
showed that both mild and severe disability measures
increased with age (p = 0.06 & p = 0.002 respectively),
with all individuals over 95 years reporting functional dis-
ability (table 2). The risk of disability increased dramati-
cally across age groups with individuals over 85 years
having at least three times the risk of individuals in the
youngest age group (table 3). Of the pathological varia-
bles Lewy bodies in any subcortical region, and in the SN,
were predictors of mild disability, though they were less
strongly associated with more severe disability. Neuronal
loss appeared to be a significant predictor of severe func-
tional disability, so that individuals who had mild-mod-
erate neuronal loss had three times the risk of those with
no loss of neurons (p = 0.008). Since all seven individuals
with Lewy bodies in the SN had mild or severe functional
disability, it was impossible to calculate an odds ratio. In
this instance, Lewy bodies perfectly predicted an outcome
of functional disability. Vascular effects in the subcortical
region were rare (only 8 individuals), and hence risk can-
not be accurately ascertained.
In assessing the combined effect of neuropathological var-
iables on functional disability, the multivariable model
The flow of individuals from recruitment until death and subsequent autopsy and examination of neuropathologyFigure 1
The flow of individuals from recruitment until death and subsequent autopsy and examination of neuropathol-
ogy. Information on the number of participants who were approached to donate brain tissue but declined was not available at 
the time of writing.
BASELINE 
Prevalence screen 
n = 13,004
Assessment at 2-yearly 
intervals 
DEATHS 
Participants who had died by 
30th June 2004 
n=7,883
Unknown dementia 
status
n=28
Demented individuals 
n=172
NON-DEMENTED 
INDIVIDUALS 
n=155
AUTOPSY SAMPLE 
Participants who donated 
brain tissue 
n=355Page 5 of 9
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showed increased severe functional disability independ-
ently of each other, though other factors were still at
increased risk.
Analyses were performed to assess how robust the results
were to uncertain decisions or assumptions that were
made about the data. Excluding 28 individuals with
reported stroke from the analysis, on the basis that stroke
is an established cause of functional disability, had no
effect on the odds ratios derived from the multivariate
model, thus confirming that functional disability follow-
ing stroke did not distort the observed clinicopathological
relationship between function and neuronal loss. Exclud-
ing information from RINI or those who died more than
one year from last interview had no effect on the odds
ratios.
Discussion
In this population-based group of donors who were not
demented before death we found that pathological meas-
ures in subcortical areas were associated with functional
disability. Plaques were not associated with impairment
and estimation of the risk for impairment associated with
NFT was not significant but greater than one. Lewy bodies
in any area were associated with greater levels of disabil-
ity. Those individuals with Lewy bodies in the substantia
nigra were all disabled. Neuronal loss was associated with
severe disability, even after adjustment for Lewy bodies,
indicating these two factors are independently associated
Table 2: Demographic characteristics and subcortical pathology of the non-demented individuals by disability status. n(%)
No disability Mild disability Severe disability
Total 43 42 68
Age at death (years)
<75 12 (28) 7 (17) 12 (18)
75–84 21 (49) 16 (38) 14 (21)
85+ 10 (23) 19 (45) 42 (62)
Men 27 (63) 18 (43) 32 (46)
Women 16 (37) 24 (57) 36 (55)
NFT 22 (51) 28 (68) 43 (63)
Neuronal loss 14 (33) 16 (39) 40 (59)
Plaques 6 (16) 4 (10) 3 (5)
Vascular disease 1 (2) 2 (5) 5 (8)
Lewy bodies 1 (2) 5 (12) 3 (4)
Lewy bodies in SN only 0 (0) 4 (10) 3 (4)
Table 3: The association of functional disability with subcortical measure of neurodegeneration.
Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)†
Mild Severe Mild Severe
Sex
Men 1.00 1.00 1.00 1.00
Women 2.3 (0.9–5.4) 1.9 (0.9–4.1) 3.4 (0.9–12.9) 1.4 (0.5–4.2)
Age at death
<75 1.00 1.00 1.00 1.00
75–84 1.3 (0.4–4.1) 0.7 (0.2–1.9) 1.2 (0.2–7.0) 0.3 (0.1–1.4)
>84 3.3 (1.0–10.9) 4.2 (1.5–12.1) 2.9 (0.5–16.2) 2.4 (1.0–9.2)
Overall effect* 1.7 (1.0–3.0) 2.3 (1.4–3.8) 1.6 (0.7–3.5) 1.7 (0.9–3.2)
SUBCORTICAL PATHOLOGY (Factor present reference absence)
NFT 2.1 (0.8–5.0) 1.6 (0.8–3.6)
Neuronal loss 1.3 (0.5–3.2) 3.0 (1.3–6.6) 1.4 (0.3–5.4) 3.9 (1.2–12.5)
Plaques 0.6 (0.1–2.2) 0.3 (0.1–1.2)
Vascular disease 2.2 (0.2–24.9) 3.3 (0.4–29.1)
Lewy bodies 8.3 (0.9–78.3) 1.8 (0.2–18.6) 8.1 (0.8–87.2) 1.2 (0.1–14.2)
LB in Substantia nigra Impossible to calculate; 100% predictive
*χ2 test for trend † Adjusted for all other effects in the table.Page 6 of 9
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absence of a definable pathology like Lewy bodies there-
fore emerge as a relevant but poorly characterised issue in
clinicopathological correlative studies. For the present
study the lack of data on neuritic synucleinopathy is a sig-
nificant limitation.
The study shows the high frequency of functional disabil-
ity in non-demented individuals aged 65 years and older
in England and Wales, and highlights the possible role of
neuronal loss in subcortical regions as a potential sub-
strate for functional decline. All individuals with Lewy
bodies in the SN were found to be disabled. A recent study
of 86 older persons revealed no relation between nigral
Lewy bodies and gait impairment typical of Parkinson's
disease after controlling for dementia status but, contrary
to the findings of this study, did find an association
between NFTs and functional impairment in non-
demented individuals[27].
The study has a number of drawbacks. Those who are
impaired are more likely to drop out, thus those individ-
uals who continue are possibly less disabled than those
who do not, but this is balanced by the fact that many
individuals develop disability in the period leading up to
death. The donor population are slightly older and with
more functional impairment than the rest of the popula-
tion that had died; this is partly due to the sampling strat-
egy which is biased towards those who are cognitively
frail. The demented donors were excluded from the anal-
yses presented here. Loss from the population who made
a 'Declaration of Intent' to donate their brains to the
actual donors may be associated with increasing frailty
but this is unlikely to lead to bias in the relationship being
examined here. The measures of disability are taken from
self- and informant-reports although it has been reported
that self-reported disability is reasonably accurate[28,29].
The measures of disability may not be sensitive enough to
brain changes which may require the use of objective
measurement. The time interval between measurement
and death may affect relationships but these are likely to
attenuate measured associations. Though there is some
possibility that in a minority of individuals function may
improve. The pathological data available for this analysis
was not specifically selected for a study of functional abil-
ity. The CERAD protocol was designed to capture data rel-
evant to dementia status not physical function. It is biased
towards capturing critical thresholds of severity in cortical
not subcortical structures. Lewy bodies, a key neuropatho-
logical variable, were detected using methods (H&E stain-
ing and ubiquitin immunocytochemistry) that precede
the development of methods based on α-synuclein.
Whilst the morphology of Lewy bodies in all these five
brain regions is readily demonstrated by H&E it is recog-
nised that additional Lewy-related pathology (e.g. Lewy
neurites) would not be detected. Thus the relationships
shown in this paper merit more detailed investigation.
The study is the largest to address the association between
neuropathological indices in subcortical areas and func-
tional disability in a non-demented cohort, However the
numbers who exhibit neuropathological changes such as
Lewy bodies are still small. The difference seen in the asso-
ciation between Lewy bodies and the severity of disability
could be due to numerical differences. The causes of func-
tional disability are often perceived to be musculoskeletal
and peripheral nervous system problems (which can also
arise from synucleinopathy) but this study and the small
number of other similar studies suggest that a more com-
plex interpretation, integrating CNS changes, may be
appropriate[17,18].
In comparison with previous findings, the reported asso-
ciation between neuronal loss and functional disability
supports evidence that neuronal loss may be a feature of
brain ageing[21,27,30]. Studies arguing that a decline in
neuronal number is not significantly associated with nor-
mal ageing[31,32] have not focussed on subcortical pop-
ulations. Given the heterogeneity in regional vulnerability
demonstrable in other age-related cerebral pathologies, it
remains possible that neuronal loss associated with func-
tional disability can occur through ageing. It is possible
that the observed relationship between neuronal loss and
function may be causal. However given that the NbM,
raphé nuclei, locus ceruleus or DEX are not convention-
ally associated with motor function suggests that the
results may reflect co-morbidity. However brain regions
conventionally regarded as 'motor', such as the cerebel-
lum, are increasingly invoked in relation to additional
non-motor functions An alternative explanation is that
neuronal loss may occur as a result of other age-related
changes responsible for the loss in function, i.e. neuronal
loss could have been a pathological confounder. The most
likely co-morbid confounder is cerebrovascular disease,
so that we looked at the potential impact of pathological
confounding by repeating the analysis to exclude patients
in whom examination of the brain showed evidence of a
stroke since these individuals have vascular pathology
likely to cause functional decline. The analysis showed no
obvious confounding but the reanalysis does not exclude
an effect of cerebrovascular disease in the absence of clin-
ical stroke or cerebral infarction. Including vascular
changes within the subcortical regions themselves did not
provide more insight, though these vascular changes were
rare in this cohort. This question requires further exami-
nation in a larger sample with greater statistical power.
Similarly, the role of Lewy bodies in the SN and func-
tional disability warrants further research on a larger sam-
ple size. Given that the findings are focused on selected
areas of the brain, additional investigations in the contextPage 7 of 9
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cal confounding.
Conclusion
The data presented offer new insights into the relationship
between changes in the brain and functional ability in
older people who are cognitively intact. Whilst the limita-
tions of the study preclude the establishment of clear
causal mechanisms, the findings indicate a neglected area
of clinicopathological enquiry into ageing and the brain.
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